Intrinsiqs

Is ARS Pharmaceuticals, Inc. overvalued?

ARS Pharmaceuticals, Inc. (SPRY) — key valuation metrics and fundamentals.

No verdict
Price
$5.65
Fair value
Current P/E
Normal P/E
Market cap
$561.1M
Dividend yield
0.0%
Return on equity
-153.6%
Sector
Healthcare

See the full interactive analysis →

Fair value compares SPRY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.